Arrowhead Pharmaceuticals reported positive phase 3 results for Redemplo, achieving 79-81% triglycer

Dow Jones up 200 pts, CME Group shares rise on upbeat earnings. Super Micro Computer, Arrowhead Phar

Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#

Statistically significant reduction in acute pancreatitis events versus placebo across the entire sH

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today an

President Donald Trump has announced that all generic drugs imported into the United States would co

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today an

JP Morgan analyst Brian Cheng maintains Arrowhead Pharma (NASDAQ:ARWR) with a Overweight and rais

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Analysts changed outlook on top names, including RXO, AMBQ, BE, ARWR, FSLR. See ratings page for upg

Stifel analyst James Condulis initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rat

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) wit

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Cardiometabolic Pipeline and Clinical Development P

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrol

Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that the European Commission (EC) has

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today an

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today an

Leerink Partners analyst Mani Foroohar maintains Arrowhead Pharma (NASDAQ:ARWR) with a Market Per

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Goldman Sachs 47th Annual Global Healthcare Confe

Arrowhead Pharmaceuticals NASDAQ: ARWR executives outlined upcoming clinical catalysts, early commer

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate i

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today an

[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today presented interim results from a P

- Targeting Activin E may represent a novel therapeutic strategy for metabolic dysfunction-associate

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today pr

[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today presented new positive clinical da

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today pr

Arrowhead Pharmaceuticals NASDAQ: ARWR executives said the company is entering a key period marked b

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Bank of America Global Healthcare Conference 2026

Arrowhead Pharmaceuticals NASDAQ: ARWR is moving into a more commercial phase while continuing to ex

Bernstein analyst William Pickering maintains Arrowhead Pharma (NASDAQ:ARWR) with a Market Perfor

Arrowhead Pharmaceuticals presents a compelling bull case with a strong pipeline and a new commercia

- Precision approach targets patients who have a mutation in the PNPLA3 gene, which is highly preval

Top Wall Street analysts changed outlooks on top names. Check analyst ratings page for all changes.

Wall Street analysts update ratings on top names. B of A Sec raised CMS Energy Corp's price targ

U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.

Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings

  During Monday's trading, 1214 companies set new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  Friday's session saw 466 companies set new 52-week highs.